Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
Ann Rheum Dis
; 2022 Jul 07.
Article
in En
| MEDLINE
| ID: mdl-35798534
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Year:
2022
Type:
Article